Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2021-02-23 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
2021年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by Guangdong Xinda Law Firm regarding the legality of the convening and procedures of the 2021 first extraordinary shareholders' meeting of Yingkang Life Technology Co., Ltd. It details the convening, attendance, voting procedures, and results of the shareholders' meeting. The document does not contain financial statements or management discussion but focuses on the legal validation of the shareholders' meeting process and voting results. This type of document is a legal opinion related to a shareholders' meeting, which is distinct from the actual voting results announcement or the meeting materials. Given the content and purpose, this fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it confirms the legality and results of the shareholder vote at the meeting. The document length is under 5,000 characters, but it is not merely an announcement of a report publication; it is a legal opinion on the meeting's validity and voting results. Therefore, the classification is DVA with high confidence.
2021-02-23 Chinese
2021年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement for the company's 2021 first extraordinary general meeting of shareholders. It details the meeting's convening, attendance, voting results on proposals, and legal opinions confirming the validity of the meeting and voting process. There is no financial data or detailed report content, but rather an official announcement of the voting results and meeting resolutions. The document length is short (2063 characters), and it focuses on the outcome of a shareholder meeting rather than the meeting materials or presentations. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-02-23 Chinese
关于召开2021年第一次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement about the convening of the 2021 first extraordinary general meeting (临时股东大会) of 盈康生命科技股份有限公司. It includes information about the meeting date, voting procedures (both onsite and online), registration methods, agenda items, and proxy voting instructions. There is no financial data, earnings information, or management discussion of results. The document is not a report itself but an announcement and instructions related to a shareholder meeting. It does not contain voting results or changes in management. Therefore, it fits best as a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2021-02-19 Chinese
回购报告书
Transaction in Own Shares Classification · 95% confidence The document is titled as a "回购报告书" which translates to "Share Repurchase Report" or "Buyback Report." It details the company's plan to repurchase its own shares, including the purpose, amount, price range, implementation period, and risks associated with the buyback. It also includes information about the authorization, shareholder plans, and regulatory compliance related to the share repurchase. The document is not a brief announcement but a detailed report on the share buyback plan and its execution. This matches the definition of "Transaction in Own Shares (POS)" which covers reports of the company buying back or selling its own shares. The document length (7973 characters) and content confirm it is a full report rather than a short announcement or regulatory filing. Therefore, the correct classification is POS with high confidence.
2021-02-08 Chinese
关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告
Transaction in Own Shares Classification · 95% confidence The document is a public announcement from a company regarding the shareholding details of the top ten shareholders and top ten unrestricted shareholders as of a specific date, in relation to a share repurchase plan approved by the board. It includes detailed tables of shareholders and their holdings, referencing a prior announcement about the share repurchase plan. The document does not contain financial statements or earnings data, nor is it a report or presentation. It is a disclosure related to the company's own shares and repurchase activities, specifically listing shareholder holdings relevant to the repurchase. Therefore, it fits best under the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2021-02-08 Chinese
安信证券股份有限公司关于公司2021年度日常关联交易预计事项的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed report from Anxin Securities regarding the 2021 anticipated related party transactions of Yingkang Life Technology Co., Ltd. It includes extensive descriptions of various related party transactions such as sales, purchases, financial services, leases, and services with affiliated companies controlled by the actual controller Haier Group. The document also provides detailed information about the related parties, their business scope, and their relationship with the company. The content is regulatory in nature, focusing on compliance with Shenzhen Stock Exchange rules and internal approval procedures for related party transactions. It is not a financial statement, earnings release, or management discussion, but rather a regulatory disclosure about related party transactions and their expected amounts, approvals, and related party descriptions. This type of document fits best under Regulatory Filings (RNS) as it is a compliance and disclosure document that does not constitute a full financial report or other specific report types.
2021-02-04 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.